|

Trametinib tablet Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 2

Top Sponsors

  • Tianjin Medical University Second Hospital1
  • Medical University of Warsaw1

Indications

  • Cardiomegaly1
  • Heart Disease1
  • Noonan Syndrome1
  • Precision Medicine1
  • Solid Tumor1

Other2 trials

MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies
Phase 2
Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.